Literature DB >> 12479863

Eph receptors and ephrins.

Juha-Pekka Himanen1, Dimitar B Nikolov.   

Abstract

Eph receptors, the largest subfamily of receptor tyrosine kinases (RTKs), and their ephrin ligands are important mediators of cell-cell communication regulating cell attachment, shape, and mobility. Eph signaling is crucial for the development of many tissues and organs including the nervous and cardiovascular systems. Both Ephs and ephrins are membrane-bound and their interactions at sites of cell-cell contact initiate unique bi-directional signaling cascades where information is transduced in both the receptor- and the ligand-expressing cells. Recent studies summarized in this review reveal how the signaling process is triggered upon ligand-receptor binding via the formation of a 2:2 circular heterotetramer. This fixes the orientation of the participating molecules and facilitates phosphorylation of their cytoplasmic domains which then interact with downstream signaling factors. The elucidation of the structural details of Eph-ephrin recognition and binding should yield insight into the future development of novel therapeutic agents targeting cardiovascular function, nerve regeneration, and cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12479863     DOI: 10.1016/s1357-2725(02)00096-1

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  30 in total

Review 1.  Spatial organization of transmembrane receptor signalling.

Authors:  Ioanna Bethani; Sigrid S Skånland; Ivan Dikic; Amparo Acker-Palmer
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

2.  Differential expression of class 3 and 4 semaphorins and netrin in the lamprey spinal cord during regeneration.

Authors:  Michael I Shifman; Michael E Selzer
Journal:  J Comp Neurol       Date:  2007-04-01       Impact factor: 3.215

3.  Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.

Authors:  Shao-Qing Kuang; Hao Bai; Zhi-Hong Fang; Gonzalo Lopez; Hui Yang; Weigang Tong; Zack Z Wang; Guillermo Garcia-Manero
Journal:  Blood       Date:  2010-01-08       Impact factor: 22.113

4.  EphB2 in the Medial Prefrontal Cortex Regulates Vulnerability to Stress.

Authors:  Ruo-Xi Zhang; Ying Han; Chen Chen; Ling-Zhi Xu; Jia-Li Li; Na Chen; Cheng-Yu Sun; Wen-Hao Chen; Wei-Li Zhu; Jie Shi; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2016-04-22       Impact factor: 7.853

5.  Low-molecular-weight protein tyrosine phosphatases of Bacillus subtilis.

Authors:  Lucia Musumeci; Cristina Bongiorni; Lutz Tautz; Robert A Edwards; Andrei Osterman; Marta Perego; Tomas Mustelin; Nunzio Bottini
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

Review 6.  Scar-modulating treatments for central nervous system injury.

Authors:  Dingding Shen; Xiaodong Wang; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2014-06-24       Impact factor: 5.203

7.  Expression of Eph A4, Eph B2 and Eph B4 receptors in AML.

Authors:  Tomasz Wrobel; Joanna Pogrzeba; Ewa Stefanko; Marcin Wojtowicz; Bozena Jazwiec; Justyna Dzietczenia; Grzegorz Mazur; Kazimierz Kuliczkowski
Journal:  Pathol Oncol Res       Date:  2014-04-25       Impact factor: 3.201

8.  Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.

Authors:  Steven Pennock; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

9.  Neuron-Subtype-Specific Expression, Interaction Affinities, and Specificity Determinants of DIP/Dpr Cell Recognition Proteins.

Authors:  Filip Cosmanescu; Phinikoula S Katsamba; Alina P Sergeeva; Goran Ahlsen; Saurabh D Patel; Joshua J Brewer; Liming Tan; Shuwa Xu; Qi Xiao; Sonal Nagarkar-Jaiswal; Aljoscha Nern; Hugo J Bellen; S Lawrence Zipursky; Barry Honig; Lawrence Shapiro
Journal:  Neuron       Date:  2018-11-19       Impact factor: 17.173

10.  Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Nathalie Amiable; Christelle Boileau; Martin Lavigne; Johanne Martel-Pelletier
Journal:  Arthritis Res Ther       Date:  2009-08-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.